ncRNA name
XIST
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
let-7i/BAG-1
Cancer name
Lung Adenocarcinoma
Cancer site
Lung
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
LncRNA XIST overexpression in A549 cells increased their chemosensitivity to cisplatin both in vitro and in vivo by protecting cells from apoptosis and promoting cell proliferation.
Tissue resource
lung adenocarcinomaand matched-normal tissue samples
human lung adenocarcinoma cell lines A549
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
China-Japan Union Hospital of Jilin University
American Type Culture Collection
Country
China
USA
Continent
Asia
Amercia